Francois Goldwasser

Francois Goldwasser

UNVERIFIED PROFILE

Are you Francois Goldwasser?   Register this Author

Register author
Francois Goldwasser

Francois Goldwasser

Publications by authors named "Francois Goldwasser"

Are you Francois Goldwasser?   Register this Author

100Publications

2977Reads

18Profile Views

Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.

Clin Nutr 2019 Aug 10. Epub 2019 Aug 10.

Medical Oncology Department, Paris Centre Teaching Hospitals, AP-HP, Paris, France; Cancer Research for PErsonalized Medicine (CARPEM), Paris, France; Paris Descartes University, USPC, Paris, France; EA 4466 PRETRAM, Pharmacy Faculty, Paris Descartes University, USPC, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnu.2019.08.003DOI Listing
August 2019

Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.

Clin Pharmacokinet 2019 Apr;58(4):451-467

UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-018-0703-0
Publisher Site
http://dx.doi.org/10.1007/s40262-018-0703-0DOI Listing
April 2019

Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?

Pharmacol Ther 2019 Apr 4;196:135-159. Epub 2018 Dec 4.

Department of Medical Oncology, CAncer Research for PErsonalized Medicine (CARPEM), Paris Centre Teaching Hospitals, Paris Descartes University, USPC, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258183021
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2018.12.003DOI Listing
April 2019

RE: Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review.

J Natl Cancer Inst 2019 Mar;111(3):335-336

AP-HP, Department of Psychiatry, Louis Mourier Hospital, Colombes, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/advance-article/doi/10.1093/jn
Publisher Site
http://dx.doi.org/10.1093/jnci/djz003DOI Listing
March 2019

[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].

Bull Cancer 2018 Dec 2;105(12):1173-1182. Epub 2018 Aug 2.

AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.06.005DOI Listing
December 2018

Mental disorders associated with recent cancer diagnosis: Results from a nationally representative survey.

Eur J Cancer 2018 12 30;105:10-18. Epub 2018 Oct 30.

AP-HP, Department of Psychiatry, Louis Mourier Hospital, Colombes, France; INSERM U894, Institute of Psychiatry and Neurosciences of Paris, Paris, France; Univ Paris Diderot, Sorbonne Paris Cite, Faculty of Medicine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.09.038DOI Listing
December 2018

[Efficacy and toxicity of immune checkpoint inhibitors in elderly patients - 5th edition of the congress of pharmacology of anticancer drugs].

Bull Cancer 2018 Dec 22;105(12):1202-1208. Epub 2018 Nov 22.

Hôpital européen Georges-Pompidou, service d'oncologie médicale, 20, rue Leblanc, 75015 Paris, France; Équipe 10 « immunothérapies et traitements anti-angiogéniques en oncologie », faculté de médecine Paris Descartes, Inserm U970, 12, rue de l'école de médecine, 75006 Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183031
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.10.004DOI Listing
December 2018

Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study.

Endocr Connect 2018 Dec;7(12):1409-1414

Pharmacokinetics and Pharmacochemistry Unit, Cochin Hospital, Paris Descartes University, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EC-18-0428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301193PMC
December 2018

A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients.

Pharmacol Res 2018 10 22;136:56-61. Epub 2018 Aug 22.

Department of Medical Oncology, Hôpital Cochin, AP-HP, Paris, France; University of Paris Descartes, CARPEM, Paris, France; Cochin Institute, INSERM U1016, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10436618183070
Publisher Site
http://dx.doi.org/10.1016/j.phrs.2018.08.016DOI Listing
October 2018

Low-Dose Abiraterone Regimen: Drug Monitoring Might Be the Key.

J Clin Oncol 2018 10 6;36(30):3061-3062. Epub 2018 Sep 6.

Manuela Tiako Meyo, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, and Cancer Research and Personalized Medicine, Paris, France; Jérôme Alexandre and François Goldwasser, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris; Cancer Research and Personalized Medicine; and Cochin Institute, Institut National de la Santé et de la Recherche Médicale U1016, Paris, France; and Benoit Blanchet, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris; Cancer Research and Personalized Medicine; and University of Paris Descartes, Université Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.3174DOI Listing
October 2018

Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences.

Crit Rev Oncol Hematol 2018 Sep 9;129:102-112. Epub 2018 Jul 9.

Centre d'Étude et de Recours aux Inhibiteurs de l'Angiogénèse, GH Cochin Port-Royal, HUPC, AP-HP, Paris Descartes, 75014 Paris, France; UF de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, AP-HP, Paris Descartes, CARPEM, 75014 Paris, France; UMR8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.06.015DOI Listing
September 2018

Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.

Drug Des Devel Ther 2017 21;11:2801-2811. Epub 2017 Sep 21.

Department of Medical Oncology, Hopital Cochin AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S109640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614734PMC
June 2018

Resting energy metabolism and anticancer treatments.

Curr Opin Clin Nutr Metab Care 2018 05;21(3):145-151

Medical Oncology Department, Cancer Research for PErsonalized Medicine (CARPEM), hôpital Cochin, Paris Centre Teaching Hospitals, Paris Descartes University, USPC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCO.0000000000000457DOI Listing
May 2018

Resting energy expenditure in the risk assessment of anticancer treatments.

Clin Nutr 2018 04 19;37(2):558-565. Epub 2017 Jan 19.

Medical Oncology Department, Cancer Research for Personalized Medicine (CARPEM), Paris Centre Teaching Hospitals, Paris Descartes University, USPC, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnu.2017.01.007DOI Listing
April 2018

[Renal toxicity of high-dose methotrexate].

Nephrol Ther 2018 Apr;14 Suppl 1:S103-S113

Service de néphrologie, hôpital Necker-Enfants-Malade, 149, rue de Sèvres, 75015 Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S17697255183003
Publisher Site
http://dx.doi.org/10.1016/j.nephro.2018.02.015DOI Listing
April 2018

Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.

Invest New Drugs 2018 02 1;36(1):156-162. Epub 2017 Aug 1.

Gastroenterology and digestive oncology unit, Cochin University Hospital, Université Paris Descartes, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0492-6DOI Listing
February 2018

Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study.

Fundam Clin Pharmacol 2018 Feb 10;32(1):98-107. Epub 2017 Nov 10.

Department of Medical Oncology, Cochin Hospital, AP-HP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/fcp.12327DOI Listing
February 2018

Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.

Invest New Drugs 2017 12 31;35(6):842-847. Epub 2017 May 31.

Department of Dermatology, Teaching Hospital Cochin, AP-HP, University Paris Descartes, 123 Bd Port Royal, 75 679, Paris Cedex 14, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0476-6DOI Listing
December 2017

Individualized Pazopanib Dosing-Letter.

Clin Cancer Res 2017 10;23(20):6377

Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1873DOI Listing
October 2017

[Clinical pharmacology and immunotherapy, 4th edition of the congress of pharmacology of anticancer drugs].

Bull Cancer 2017 Sep 4;104(9):807-811. Epub 2017 Aug 4.

Assistance publique-Hôpitaux de Paris, hôpital Cochin, service d'oncologie médicale, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551173016
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2017.06.005DOI Listing
September 2017

Reply to N Dominguez and T Canada.

Am J Clin Nutr 2017 09;106(3):958-959

From the Department of Medical Oncology, Cochin Teaching Hospital, AP-HP, Paris Descartes University, Paris, France (AJ; J-PD; FG; CV, e-mail: and Laboratory Biol. Nutrition EA 4466, Pharmacy, Paris Descartes University, Paris, France (LC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.117.162107DOI Listing
September 2017

Patient-specific blood pressure correction technique for arterial stiffness: evaluation in a cohort on anti-angiogenic medication.

Hypertens Res 2017 Aug 16;40(8):752-757. Epub 2017 Mar 16.

Department of Biomedical Engineering, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/hr.2017.32DOI Listing
August 2017

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

Invest New Drugs 2017 08 10;35(4):436-441. Epub 2017 Apr 10.

Department of Dermatology, CERTIM Group, Cochin Port-Royal Hospital, AP-HP, University Paris Descartes, 123 Bd Port-Royal, 75 679, Paris Cedex 14, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0464-xDOI Listing
August 2017

A simple HPLC-UV method for quantification of enzalutamide and its active metabolite N-desmethyl enzalutamide in patients with metastatic castration-resistant prostate cancer.

J Chromatogr B Analyt Technol Biomed Life Sci 2017 Jul 5;1058:102-107. Epub 2017 Apr 5.

Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2017.04.014DOI Listing
July 2017

Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.

Clin Genitourin Cancer 2017 06 1;15(3):e493-e495. Epub 2017 Feb 1.

Department of Medical Oncology, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.01.017DOI Listing
June 2017

Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients.

J Pharm Biomed Anal 2017 May 24;139:30-36. Epub 2017 Feb 24.

Department of Pharmacokinetics and Pharmacochemistry, Hôpital Cochin, AP-HP, Paris, France; Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Hôpital Cochin, AP-HP, Paris, France; Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2017.02.041DOI Listing
May 2017

Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old.

Invest New Drugs 2017 04 29;35(2):242-246. Epub 2016 Oct 29.

Department of Medical Oncology, Cochin - Port Royal Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité 123, Boulevard de Port-Royal, 75014, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0400-5DOI Listing
April 2017

Restoring Radioiodine Uptake in Mutated Papillary Thyroid Cancer.

J Endocr Soc 2017 Apr 21;1(4):285-287. Epub 2017 Feb 21.

Department of Endocrinology, Hôpital Cochin, 75014, Paris, France, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/js.2016-1114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686703PMC
April 2017

Malnutrition in Patients With Cancer.

JPEN J Parenter Enteral Nutr 2017 Jan 1:148607116688881. Epub 2017 Jan 1.

11 Gastroenterology and Clinical Nutrition, Nice Teaching Hospital (CHU) and University of Nice Sophia-Antipolis Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0148607116688881DOI Listing
January 2017

Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.

Expert Opin Drug Metab Toxicol 2016 Dec 24;12(12):1433-1444. Epub 2016 Aug 24.

a Department of Medical Oncology, CERIA , Paris Descartes University, AP-HP, Cochin Hospital , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2016.1225038DOI Listing
December 2016

Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients.

Pharmacol Res 2016 11 1;113(Pt A):709-718. Epub 2016 Jul 1.

Assistance Publique Hôpitaux de Paris, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.06.032DOI Listing
November 2016

Vemurafenib for BRAF-positive metastatic papillary thyroid cancer.

Lancet Oncol 2016 11;17(11):e468

Department of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30499-5DOI Listing
November 2016

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals.

Eur J Cancer 2016 10 15;66:75-82. Epub 2016 Aug 15.

Department of Neurology, OncoNeuroTox Center, Paris, France; Department of Neurology, Val-de-Grâce Teaching Hospital, Service de Santé des Armées, 74, boulevard de Port Royal, 75005 Paris, France; Department of Neurology, Cognition an Action Group (COGNAC-G) UMR 8257 Centre National de la Recherche Scientifique, Service de Santé des Armées, Paris Descartes University, 45, rue des Saints-Pères, 75006 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.07.008DOI Listing
October 2016

A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian Carcinoma.

Int J Gynecol Cancer 2016 09;26(7):1196-200

Departments of *Medical Oncology and †Gynecology Oncology, Cochin-Port Royal Hospital, Sorbonne Paris-Cité University, Cancer Personalized Medicine, Assistance Publique-Hôpitaux de Paris; and ‡Women Cancer Clinical Research Unit, Hotel Dieu, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000833DOI Listing
September 2016

Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation.

Dermatology 2015 10;231(4):378-84. Epub 2015 Oct 10.

Service de Dermatologie, Hx00F4;pital Cochin, Assistance Publique - Hx00F4;pitaux de Paris (APHP), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000439400DOI Listing
August 2016

[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management].

Bull Cancer 2016 Mar 29;103(3):259-72. Epub 2016 Jan 29.

Hôpitaux universitaires Paris centre, université Paris Descartes, CERIA, Center for Research on Angiogenesis Inhibitors, ARIANE, hôpital Broca, hôpital Cochin-Port-Royal, service d'oncologie médicale, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.10.020DOI Listing
March 2016

Treatment of Advanced Renal-Cell Carcinoma.

N Engl J Med 2016 03;374(9):888

Hôpital Cochin, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1515613DOI Listing
March 2016

Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy.

Clin Genitourin Cancer 2016 Feb 6;14(1):e95-7. Epub 2015 Aug 6.

Medical Oncology, Cochin Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris-Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.013DOI Listing
February 2016

Angiotensin System Inhibitors in Renal Cell Carcinoma--Letter.

Clin Cancer Res 2016 Jan;22(2):524

Department of Medical Oncology, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2102DOI Listing
January 2016

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-Letter.

Clin Cancer Res 2015 Dec;21(24):5639

Department of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1648DOI Listing
December 2015

Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters.

Cancer Chemother Pharmacol 2015 Nov 29;76(5):1033-9. Epub 2015 Sep 29.

Medical Oncology Department, CAncer PErsonalized Medicine, Cochin - Port Royal Hospital, Sorbonne Paris Cité University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2875-8DOI Listing
November 2015

Large artery stiffness and hypertension after antiangiogenic drugs: influence on cancer progression.

J Hypertens 2015 Jun;33(6):1310-7

aUniversité Paris-Descartes bINSERM U970 cAssistance Publique-Hôpitaux de Paris dDepartment of Pharmacology eClinical Investigation Center, Hôpital Européen Georges Pompidou fDepartment of Oncology, CERIA, Hôpital Cochin, Paris, France *Maureen Alivon and Julie Giroux contributed equally to the writing of this article.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000000550DOI Listing
June 2015

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.

Expert Opin Investig Drugs 2015 May 20;24(5):673-87. Epub 2015 Jan 20.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.2015.10
Publisher Site
http://dx.doi.org/10.1517/13543784.2015.1005736DOI Listing
May 2015

Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib.

Expert Opin Drug Metab Toxicol 2015 May 25;11(5):785-94. Epub 2015 Mar 25.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France 33 1 58 41 17 46 ; 33 1 58 41 17 45 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2015.1030392DOI Listing
May 2015

A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer.

J Chromatogr B Analyt Technol Biomed Life Sci 2015 May 9;989:86-90. Epub 2015 Mar 9.

Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2015.03.001DOI Listing
May 2015

[Respecting patient's end of life wishes: feasibility study of an information on surrogate and advance directives].

Bull Cancer 2015 Mar 27;102(3):234-44. Epub 2015 Feb 27.

AP-HP, groupe hospitalier Cochin Broca Hôtel-Dieu, unité fonctionnelle de médecine palliative, 75679 Paris cedex 14, France; Université de Paris Descartes, 75006 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.01.009DOI Listing
March 2015

Sorafenib for patients with differentiated thyroid cancer.

Lancet 2015 Jan;385(9964):227-8

Medical Oncology and Pharmacology, CERIA, Cochin-Port Royal Hospital, AP-HP, Paris, 75014, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60054-XDOI Listing
January 2015

Sorafenib for patients with differentiated thyroid cancer.

Lancet 2015 Jan;385(9964):227

Departments of Medical Oncology, Cochin Hospital, Paris, 75006, France; Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60053-8DOI Listing
January 2015

The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab.

Anticancer Drugs 2014 Nov;25(10):1215-9

aGastroenterology and Digestive Oncology Unit, Department of Gastroenterology bDepartment of Medical Oncology, Cochin Teaching Hospital, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris cDepartment of Cancer Medicine, Gustave Roussy Cancer Institute, University of Paris-Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000129DOI Listing
November 2014

[Biotherapies in metastatic colorectal cancers in 2014].

Presse Med 2014 Oct 24;43(10 Pt 1):1056-66. Epub 2014 Jul 24.

AP-HP, groupe hospitalier Cochin-Port-Royal, université Paris-Descartes, service de cancérologie, 75014 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2014.03.028DOI Listing
October 2014

Sorafenib in thyroid cancer patients: learning from toxicity.

Oncologist 2014 Aug 22;19(8):e3. Epub 2014 Jul 22.

Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122476PMC
August 2014

Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer.

Nutr Cancer 2013 7;65(8):1254-7. Epub 2013 Oct 7.

a Department of Medical Oncology, Cochin Teaching Hospital, Assistance Publique-Hôpitaux de Paris , Paris Descartes University , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2013.830315DOI Listing
June 2014

Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer.

Invest New Drugs 2014 Jun 8;32(3):569-72. Epub 2014 Jan 8.

CERIA, Centre for Research on Angiogenesis Inhibitors, Department of Medical Oncology, Cochin Teaching Hospital, AP-HP, Université Paris Descartes, 27, rue du faubourg Saint Jacques, 75014, Paris, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-0052-7DOI Listing
June 2014

Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?

BMC Cancer 2014 Jun 10;14:416. Epub 2014 Jun 10.

Radiation Oncology Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057924PMC
June 2014

Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.

Expert Opin Drug Saf 2014 May 3;13(5):663-73. Epub 2014 Apr 3.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France +33 1 58 41 17 46 ; +33 1 58 41 17 45 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2014.90
Publisher Site
http://dx.doi.org/10.1517/14740338.2014.907270DOI Listing
May 2014

Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies.

Med Oncol 2013 10;30(3):656. Epub 2013 Jul 10.

Gastro-Enterology and Digestive Oncology Unit, Cochin Teaching Hospital, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-013-0656-yDOI Listing
April 2014

Prevalence of malnutrition and current use of nutrition support in patients with cancer.

JPEN J Parenter Enteral Nutr 2014 Feb;38(2):196-204

Gastroenterology and Clinical Nutrition, Nice Teaching Hospital (CHU), University of Nice Sophia-Antipolis, Nice.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1177/0148607113502674
Publisher Site
http://dx.doi.org/10.1177/0148607113502674DOI Listing
February 2014

Drug interactions with solid tumour-targeted therapies.

Crit Rev Oncol Hematol 2014 Jan 28;89(1):179-96. Epub 2013 Aug 28.

Centre d'Étude et de Recours aux Inhibiteurs de l'Angiogénèse, Paris, France; Service d'Oncologie Médicale, Groupement des Hôpitaux Paris Centre, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.08.007DOI Listing
January 2014

Pancreatic atrophy from sorafenib.

N Engl J Med 2014 01;370(2):186

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1313753DOI Listing
January 2014

Pancreatic atrophy--a new late toxic effect of sorafenib.

N Engl J Med 2013 Oct;369(15):1475-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1305302DOI Listing
October 2013

An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients.

J Chromatogr B Analyt Technol Biomed Life Sci 2013 Jun 25;928:93-7. Epub 2013 Mar 25.

Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2013.03.017DOI Listing
June 2013

Cervical extravasation of bevacizumab.

Anticancer Drugs 2013 Apr;24(4):426-8

Departments of Gastroenterology, Cochin Teaching Hospital, AP-HP, Sorbonne Paris Cité, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32835cfef1DOI Listing
April 2013

Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.

J Immunol 2012 Dec 26;189(11):5171-7. Epub 2012 Oct 26.

Université Paris Descartes, Sorbonne Paris Cité, Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1103094
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1103094DOI Listing
December 2012